Katsuya Ohbuchi

15PUBLICATIONS
12CO-AUTHORS
Neurology and neuromuscular diseasesTraditional Chinese medicine and treatmentsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 23, 2025
Hypomyelinating Leukodystrophy 14 (HLD14)-Related UFC1 p.Arg23Gln Decreases Cell Morphogenesis: A Phenotype Reversable with Hesperetin.

Yuri Ichihara, Maho Okawa, Minori Minegishi

|May 11, 2024
The Inhibition of TREK-1 K+ Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways.

Kanako Miyano, Miki Nonaka, Masahiro Sakamoto

|Feb 23, 2024
Modulating Golgi Stress Signaling Ameliorates Cell Morphological Phenotypes Induced by CHMP2B with Frontotemporal Dementia-Associated p.Asp148Tyr.

Shoya Fukatsu, Maho Okawa, Miyu Okabe

|Feb 23, 2024
Rab11a Controls Cell Shape via C9orf72 Protein: Possible Relationships to Frontotemporal Dementia/Amyotrophic Lateral Sclerosis (FTDALS) Type 1.

Shoya Fukatsu, Hinami Sashi, Remina Shirai

|May 13, 2023
Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses.

Eiko Uezono, Yusuke Mizobuchi, Kanako Miyano

|Mar 28, 2023
Hesperetin Ameliorates Inhibition of Neuronal and Oligodendroglial Cell Differentiation Phenotypes Induced by Knockdown of Rab2b, an Autism Spectrum Disorder-Associated Gene Product.

Yukino Kato, Remina Shirai, Katsuya Ohbuchi

Pageof 3

Frequent Collaborators

10 joint publications

Junji Yamauchi

8 joint publications

Yuki Miyamoto

2 joint publications

Miki Nonaka

1 joint publications

Atsushi Kaneko